NCT05846646 2025-10-20Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCCImmuneSensor Therapeutics Inc.Phase 2 Terminated6 enrolled 7 charts
NCT05846659 2024-12-09Study of PULSAR-ICI +/- IMSA101 in Patients with Oligoprogressive Solid Tumor MalignanciesImmuneSensor Therapeutics Inc.Phase 2 Terminated16 enrolled